DNA Script
founded in 2014, DNA Script commercialises enzymatic DNA synthesis on its SYNTAX benchtop printer using engineered TdT, moving synthesis from centralised factories toward the bench.
- Country
- United States
Commercial
SYNTAX enzymatic DNA printer (engineered TdT); founded 2014
us
Coverage
| CN | EU | US | |
|---|---|---|---|
| foundries-design | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| DNA synthesis & gene foundry | foundries-design | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.